Detalhe da pesquisa
1.
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation.
J Biol Chem
; 291(32): 16659-71, 2016 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27284008
2.
Mechanisms by which Factor H protects Trypanosoma cruzi from the alternative pathway of complement.
Front Immunol
; 15: 1152000, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38361922
3.
Proprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation.
J Biol Chem
; 291(51): 26586, 2016 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27986868
4.
A Factor H-Fc fusion protein increases complement-mediated opsonophagocytosis and killing of community associated methicillin-resistant Staphylococcus aureus.
PLoS One
; 17(3): e0265774, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35324969
5.
An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae.
Front Immunol
; 13: 975676, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36110842
6.
Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax.
Antimicrob Agents Chemother
; 55(1): 132-9, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20956592
7.
Development of Complement Factor H-Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae.
Front Immunol
; 11: 583305, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33193396